Azoulay Salomon 4
4 · MBX Biosciences, Inc. · Filed Feb 5, 2025
Insider Transaction Report
Form 4
Azoulay Salomon
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-03+90,000→ 90,000 totalExercise: $10.49Exp: 2035-02-03→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option vest and become exercisable on February 3, 2026, with the remaining 75% vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on such vesting date.